Physician profile
Mary Agnes Walker
NPI 1629039516
$239.83
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.46 · 2021: $14.78 · 2022: $28.42 · 2023: $77.78 · 2024: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $43.99 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $33.15 | 2024 | Farxiga, Breztri |
| Lilly USA, LLC | $30.06 | 2022-2023 | Trulicity, Mounjaro |
| Novo Nordisk INC | $19.39 | 2024 | Wegovy |
| Melinta Therapeutics, LLC | $17.46 | 2019 | |
| Daiichi Sankyo INC. | $17.43 | 2024 | Injectafer |
| Shield Therapeutics INC | $16.60 | 2023 | Accrufer |
| Astellas Pharma US INC | $16.48 | 2024 | Veozah |
| Esperion Therapeutics, INC. | $15.60 | 2023 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $14.94 | 2024 | |
| Abbott Laboratories | $14.73 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.